- Home
- / Lilly
Lilly
Stock Price
$903.6
2024-10-29
Market Capitalization
$903.4 B
2024-08-26
Revenue
$65.2 B
FY, 2025
Lilly Summary
Company Summary
- Overview
- Eli Lilly is a company that discovers, develops, manufactures, and markets pharmaceutical products. It offers diabetes, oncology, immunology, and neuroscience products and therapies. The company serves pharmacies, physicians, and other healthcare professionals and hospitals.
- Type
- Public
- Status
- Active
- Founded
- 1876
- HQ
- Indianapolis, IN, US | view all locations
- Website
- https://www.lilly.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Daniel M. Skovronsky, Executive Vice President, Chief Scientific and Medical Officer, and President, Lilly Research Laboratories
Anat Ashkenazi, Senior Vice President and Chief Financial Officer
Patrik Jonsson, Senior Vice President; President, Lilly Immunology; President, Lilly USA; and Chief Customer Officer
Operating MetricsView all
Facilities Owned (US), sq. ft.
8.1M
1.2%
FY, 2021
Facilities Owned, sq. ft.
12.8M
1.6%
FY, 2021
Phase I Trials Products
27
FY, 2019
LocationsView all
50 locations detected
Indianapolis, IN HQ
United States
893 Delaware St
Branchburg, NJ
United States
33 Imclone Dr
Cambridge, MA
United States
450 Kendall St
Indianapolis, IN
United States
1223 W Morris St
Indianapolis, IN
United States
1555 S Harding St
New York, NY
United States
450 E 29th St 12th floor
Lilly Financials
Summary Financials
- Revenue (Q1, 2026)
- $19.8B
- Gross profit (Q1, 2026)
- $16.2B
- Net income (Q1, 2026)
- $7.4B
- Cash (Q1, 2026)
- $5.3B
- Enterprise value
- $941.5B